h5欢乐红包扫雷源码

Press Releases

FEBRUARY 2020

07.02.2020
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE: ANNOUNCES THE APPOINTMENT OF CHIEF SCIENTIFIC ADVISOR DAVID C. RUBINSZTEIN

Professor Rubinsztein is a leader in the field of neurodegenerative disease and autophagy.

h5欢乐红包扫雷源码berlin/london, 07 february 2020 - aladdin healthcare technologies se (“aladdin”, isin: de000a12ull2), today announces that professor david c. rubinsztein has been appointed as chief scientific advisor. david is the deputy director of the cambridge institute of medical research, professor of molecular neurogenetics at the university of cambridge and uk dementia research institute professor. his research interests are in autophagy and neurodegeneration.

h5欢乐红包扫雷源码he is a fellow of the royal society and the academy of medical sciences. david is a highly cited researcher from clarivate analytics and thomson reuters. he has published more than 390 papers, including studies in well-known international journals like nature and cell, with more than 75,000 google scholar citations.

h5欢乐红包扫雷源码“i am delighted to welcome professor david c. rubinsztein as chief scientific advisor,” said wade menpes-smith, ceo of aladdin healthcare technologies se. “as a leader within his industry, he will bring enormous experience and expertise in the fields of neurodegenerative disease and advise the product direction of our company. moreover, david will help with the validation process of the various prototypes on aladdin’s ‘early diagnosis platform’. he will also lead the development of aladdin’s neurodegenerative disease-centric knowledge graph, which aims to achieve disease pathway discovery, target discovery and novel biomarker discovery.

wade menpes-smith (chairman)

About Aladdin Healthcare Technologies SE

Website Link: www.nouub.icu
WKN: A12ULL
ISIN: DE000A12ULL2
h5欢乐红包扫雷源码 TICKER SYMBOL: NMI

h5欢乐红包扫雷源码aladdin healthcare technologies se (and its wholly owned subsidiary aladdin healthcare technologies ltd.) is a leading developer of ai healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. aladdin targets age-related disease including a significant focus on alzheimer’s disease. aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including genomic, mri, pet, cognition and other lifestyle data. these datasets are then analysed by our award-winning ai team and used to develop proprietary ai tools that can assist healthcare professionals to more accurately and efficiently diagnose aged related diseases. this new diagnostic process will save significant time and costs for healthcare professionals. additionally, our ai drug discovery platform will be used by pharmaceutical companies to speed up drug development, clinical trials and predict outcomes more accurately.

04.02.2020
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE: ANNOUNCES WE HAVE ACHIEVED A TOP FIVE POSITION IN KAGGLE’S GLOBAL DATA SCIENCE BOWL 2019

(berlin, germany and london, england) 04 february 2020 - aladdin healthcare technologies se (“aladdin”), is proud to announce that two of its senior engineers, who are kaggle grand masters, placed 5th out of 3,497 teams in the prestigious global data science bowl competition. again, one of aladdin’s ai solutions has proven to be at a world class level. a standard that should set aladdin on the path to innovation in global healthcare.

aladdin’s a.i team has achieved a large number of a.i competition 1st prize awards, including the first prize of 2018 acm kdd cup, dcic 2019. and a large number of publications, including miccai, nature machine intelligence, ieee, bioinformatics etc.

What is Data Science Bowl (DSB)?

dsb is the world’s largest data science competition focused on social good. each year, this competition gives kagglers a chance to use their passion to change the world. over the last four years, more than 50,000+ kagglers have submitted over 114,000+ submissions, to improve everything from lung cancer and heart disease detection to ocean health. datasciencebowl.com

h5欢乐红包扫雷源码reference:

h5欢乐红包扫雷源码wade menpes-smith (chairman)

About Aladdin Healthcare Technologies SE

aladdin healthcare technologies se (and its wholly owned subsidiary aladdin healthcare technologies ltd.) is a leading developer of ai healthcare diagnostics and drug discovery applications that can accelerate both early stage disease diagnosis and the end-to-end drug discovery process. aladdin targets aged related disease including a significant focus on alzheimer’s disease. aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to confidentially and securely gather targeted data including, genome, tabular, mri, pet, cognition and other lifestyle data. these datasets are then analysed by our award-winning ai team and used to develop proprietary ai tools that can assist healthcare professionals to more accurately and efficiently diagnose aged related diseases. this new diagnostic process will save significant time and costs for healthcare professionals. additionally, our ai drug discovery platform will be used to by pharmaceutical companies to speed up drug development, clinical trials and predict outcomes more accurately.

Website Link: www.nouub.icu
WKN: A12ULL
ISIN: DE000A12ULL2
TICKER SYMBOL: NMI

JANUARY 2020

16.01.2020
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE: ANNOUNCES WE HAVE DEVELOPED A PROTOTYPE A.I POWERED DATA ANALYSIS PLATFORM FOR BRAIN IMAGING

(berlin, germany and london, england) 16 january 2020 - aladdin healthcare technologies se (“aladdin”), a leading developer of next generation breakthroughs in age- related disease accelerated by the integration of leading science and a.i today announces we have developed a prototype a.i powered data analysis platform for brain imaging.

h5欢乐红包扫雷源码our technological breakthrough means the prototype can process brain imaging data with the assistance of deep learning models. the novel application that can solve a number of issues regarding alzheimer’s disease (ad) data analysis and computer aided diagnosis (cad) with multiple analytics solutions for early detection and patient management.

h5欢乐红包扫雷源码currently within the healthcare industry, there are a several issues with brain data analysis software that is being used within hospitals, issues such as:

  • Limited functions requiring a significant amount of manual work and interventions.
  • Inaccurate single modality analysis and limited support for different types of data.
  • Limited connectivity and insecure databases.

Major Benefits for healthcare professionals and patients worldwide

h5欢乐红包扫雷源码the following new features and attributes that the platform delivers, subject to cfda and ce mark approval, pave the way for a new generation of ad analytics tool that can significantly increase early stage diagnosis accuracy, workflow efficiency and lead to enhanced affordability. one corresponding patent application have been applied (and another 3 will be submitted in 2 months) for the chinese market.

Key Features:

  • Full and/or semi-automated analysis powered by recently developed A.I algorithms.
  • Full support for multimodal imaging data including Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI).
  • Highlighting the areas of potential disease, such as hippocampus area segmentation for Alzheimer’s Disease, and other age-related diseases based on our A.I diagnosis model.
  • A cloud-based frontend and data privacy-preserved platform.

h5欢乐红包扫雷源码aladdin’s ability to combine multimodal data with specifically integrated a.i driven blood analysis makes for a novel approach to early diagnostics. moreover, most other a.i approaches, currently available within the industry, reflect the reliance on utilising brain images as a singular approach methodology. this is only adequate for basic diagnosis and does not approach the multiple complexities that involve the disease and its underlying pathways.

wade menpes-smith (chairman)

end of media release

08.01.2020
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE RELEASE A SAAS PROTOTYPE FOR EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE BASED ON BLOOD TEST RESULTS

h5欢乐红包扫雷源码(berlin, germany and london, england) 08 january 2020 - aladdin healthcare technologies se (“aladdin”), a leading developer of next generation breakthroughs in age-related disease accelerated by the integration of leading science and a.i today announced we have released our saas (software as a service) based online rapid analysis report prototype, for early diagnosis for alzheimer’s disease, based on blood test results.

h5欢乐红包扫雷源码ageing is a global megatrend, as the world continues to age rapidly, age-related diseases have become a significant healthcare burden for all governments. alzheimer’s disease is one of the most crippling age-related diseases, there are more than 50 million dementia patients globally which created a global economic burden of more than $1 trillion in 2018.

h5欢乐红包扫雷源码currently there is no affordable and accurate early stage universal testing for alzheimer’s disease. all methods are either invasive and painful, expensive or inaccurate.

h5欢乐红包扫雷源码our a.i diagnosis is based on a non-invasive blood test, which can provide instant diagnosis for health screening of multiple age-related diseases. we have achieved 85% accuracy for diagnosing alzheimer’s disease through our a.i model based on blood test results. these diagnostics will now be validated through our extensive and industry leading hospital network. this is a catalyst for our second phase, which potentially will make further significant gains and breakthroughs towards a seamless blood test that setting a new gold standard for alzheimer’s disease early diagnosis.

evidence shows that early diagnosis and intervention of key diseases can not only help postpone or ameliorate symptoms but also lead to enhanced longevity. on top of this, early diagnosis is also a significant component for pharmaceutical companies to gain access to a key demographic for clinical trials that can expedite drug discovery.

the ceo, wade menpes-smith states “this is clearly a significant breakthrough moment for aladdin and fundamentally transforms the outlook for the company. i’m satisfied we have met the first milestone for this product, and we look forward to both validating our product with our gloablly respected partnership network and further improving the accuracy.”

wade menpes-smith (chairman)

h5欢乐红包扫雷源码end of media release

DECEMBER 2019

12.12.2019
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE ANNOUNCES IT HAS CO-PUBLISHED A SCIENTIFIC PAPER ON AI TO TARGET AGEING

(berlin, germany and london, england) 12 december 2019 - aladdin healthcare technologies se (“aladdin”), a leading developer of next generation breakthroughs in age-related disease accelerated by the integration of leading science and ai today announced it has co-published a scientific paper, in the ‘mechanisms of ageing and development’ journal within science direct by elsevier.

the paper titled, ‘the nad+-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications’, delves into the concept that nad+ could hold the key to early diagnosis and delay of neurodegenerative diseases. the paper focuses on 3 key points:

  • Summarizing the importance of NAD+ and mitophagy in healthy longevity.
  • Proposing an NAD+-mitophagy axis in health and disease, especially in neurodegenerative diseases.
  • Discuss the importance and how to use artificial intelligence (AI) in the NAD+-mitophagy axis-based mechanistic studies, drug development.

h5欢乐红包扫雷源码advances in our understanding of the molecular and cellular roles of nad+ in mitophagy will lead to novel approaches for facilitating healthy mitochondrial homoeostasis that could serve as a promising therapeutic strategy to counter ageing-associated pathologies and/or accelerated ageing.

the paper shows that by collaborating with academic and medical partners aladdin is changing the approach to early diagnosis of age-related disease using our strong ai capability. this forms the foundation for innovation into new products within this market.

h5欢乐红包扫雷源码please follow this link to access the full paper: http://www.sciencedirect.com/science/article/abs/pii/s004763741930199x

wade menpes-smith (chairman)

end of media release

JULY 2019

12.07.2019
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE ANNOUNCES IT HAS ENTERED INTO A MEMORANDUM OF UNDERSTANDING WITH THE IMPERIAL INSTITUTE OF ADVANCED TECHNOLOGY

h5欢乐红包扫雷源码(berlin, germany and london, england) 12 july, 2019 - aladdin healthcare technologies se (“aladdin”), a leading developer of ai healthcare diagnostics and drug discovery applications, today announced it has entered into a memorandum of understanding (mou) with imperial institute of advanced technology (iaat).

iaat has been established by a team of royal academicians and professors from imperial college london and royal brompton hospital. it is a new research and development institute engaging the international exchange and cooperation in science and technology, chinese-european technology transfer, and research in medical imaging technology. it is also committed to bringing human resources, technologies, projects in the field of healthcare from europe to china, and promoting them in china.

h5欢乐红包扫雷源码the mou enables aladdin to host and open its greater china office from a leading science park in hangzhou china home to multiple unicorn technology companies. the mou also acts as a prelude to a contractual partnership that will enable aladdin to jointly develop ai healthcare applications, ai software toolkits for drug discovery, fast track chinese food and drug administration (cfda) applications, commercial ai software distribution and access government funding with iaat. this includes iaat granting aladdin access to both its china and international partners and healthcare contacts.

h5欢乐红包扫雷源码aladdin places real significance on this future partnership as a further access point to the chinese healthcare market and to further assist in the development and commercialisation of its ai applications.

wade menpes-smith (chairman)

h5欢乐红包扫雷源码end of media release

MAY 2019

21.05.2019
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE SIGNS A PARTNERSHIP AGREEMENT WITH THE NORWEIGIAN CENTRE ON HEALTHY AGEING (NO-Age)

(berlin, germany and london, england) 21 may 2019 - aladdin healthcare technologies se (“aladdin”), a cutting edge technology leader developing ai for innovative healthcare solutions that will ensure every dollar in healthcare is spent more efficiently, today announced the signing of a partnership with the norwegian centre on healthy ageing (no-age). no-age and aladdin have agreed to collaborate, innovate and transform the future of digital healthcare, bringing positive health outcomes to people who have ageing-related chronic diseases, such as alzheimer’s disease (ad), cardiovascular diseases, and diabetes. the parties intend to focus on the following three specific areas, which will enable the development of superior ai diagnosis toolkits for early disease detection, clinical trials and research and development for key compounds, with a view to new drug and treatment discovery.

  • To develop mitophagy targeted biomarkers for AD with AI assistance.
  • To develop a machine learning platform for the detection and analysis of NAD+, to speed up the clinical trial and drug discovery process.
  • To develop a screening and early diagnostic tool for AD using AI with tabular data, retina images, brain CT and MRI images, quizzes and IoT recorded walking path data.

h5欢乐红包扫雷源码wade menpes smith, ceo of aladdin healthcare technologies, highlights the importance of this first collaboration with a nordic institute, “we are delighted to be entering into this partnership and looking forward to combining aladdin’s technological expertise with no-age’s medical experience, in an attempt to confront alzheimer’s disease. the world health organisation believes alzheimer’s disease will be a global epidemic by 2050 so action against it needs to be taken imminently.”

the partnership brings together a combination of world-class doctors, scientists, ai engineers from leading medical and research institutes. both parties view the partnership as a fundamental forward step to achieve the end goal of accelerating medical research and transforming patient care.

About Aladdin Healthcare Technologies SE

aladdin healthcare technologies se (and its wholly owned subsidiary aladdin healthcare technologies ltd.) is a cutting edge technology company leveraging blockchain, artificial intelligence and machine learning techniques to ensure every dollar in healthcare is spent more efficiently. aladdin accomplishes this by collaborating with numerous partners within the global healthcare ecosystem to ethically and securely gather large sets of health and lifestyle data. these datasets are then analysed and used to reduce costs and improve the efficiency of healthcare treatments. aladdin’s analysis can identify trends related to chronic diseases, thus empowering patients by providing insight into the various elements affecting their health, while improving outcomes and overall access to healthcare. aladdin’s vision is to move toward an era of more efficient healthcare management and realise their purpose of improving global health outcomes.

About Norwegian Centre on Healthy Ageing (NO-Age)

norwegian centre on healthy ageing (no-age), a virtual norwegian integrated, interdisciplinary, international centre for human ageing research, with a translational goal to empower people to live longer, healthier, and more meaningful lives (official website: www.noage100.com). no-age is anchored on ahus. the current no-age centre network consists of members and research groups from world leading universities (europe: u of oslo, cambridge, oxford, ulc, u of copenhagen; u.s: harvard university, u of washington, national institutes of health (nianih), stanford, princeton, buck institute for research on aging; asia: university of hong kong, sun yat-sen university). no-age aims to employ a common conceptual framework to understand the complex interplay of biological, physiological, cultural, and social factors that influence health and wellbeing at both the individual and population levels. no-age actively engages with our stakeholders to develop interventional strategies and policies to promote healthy living and social participation at old age. the maintenance of a healthy ageing brain is currently a primary goal of no-age. with a combinational approach of cross species laboratory experiments, artificial intelligence (ai), and clinical patient samples, no-age aims to focus on the most common dementia, alzheimer’s disease (ad), covering all the major aspects of ad research including novel etiologies, early biomarker development, drug screening, and clinical trials. the final aim of no-age is to have norway as an international research and development hub on normal ageing, and the age predisposed ad.

h5欢乐红包扫雷源码end of media release

JANUARY 2019

23.01.2019
DGAP-Media

ALADDIN HEALTHCARE TECHNOLOGIES SE ANNOUNCES A TOTAL OF 2.3 MILLION ANONYMISED EMRS ON ITS PLATFORMS GLOBALLY

(berlin, germany and london, england) 23rd january, 2019 ­ aladdin healthcare technologies se (“aladdin”), a cutting­edge technology leader developing ai for innovative healthcare solutions that will ensure every dollar in healthcare is spent more efficiently, today announced it has increased the number of anonymised electronic medical records (emrs), of patients from india, on its platform by 120,000. this brings the total number of anonymised emrs, on aladdin’s platforms to 2,310,000.

this represents further significant progress into the indian market, the numbers will continue to increase on a monthly basis feeding into the aladdin platforms. thereby improving the accuracy and effectiveness of aladdin’s ai and deep learning tools, which will help to enable the early detection and prevention of chronic disease. this is, therefore, a very exciting development for aladdin.

h5欢乐红包扫雷源码aladdin will leverage its ai and deep learning capabilities for the purpose of assisting medical research by aiming to identify effective preventive medicinal practices, which in turn can optimise healthcare spending and generate savings for the healthcare industry.

wade menpes smith (chairman)

end of media release

NOVEMBER 2018

01.11.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE ANNOUNCES A TOTAL OF 1.8 MILLION ANONYMISED EMRS ON ITS PLATFORMS

h5欢乐红包扫雷源码(berlin, germany and london, england) 01 november, 2018 ­ aladdin blockchain technologiesholding se (“aladdin”), a cutting­edge technology leader developing a new digital healthcare ecosystem that will ensure every dollar in healthcare is spent more efficiently, today announced it has increased the number of anonymised electronic medical records (emrs) of patients from china on its platform by 635,000. this brings the total number of anonymised emrs, on aladdin’s platforms to 1,845,000.

h5欢乐红包扫雷源码this represents significant progress into the chinese market, the numbers will continue to increase on a monthly basis feeding into the aladdin platforms. thereby improving the accuracy and effectiveness of aladdin’s artificial intelligence (ai) and machine learning (ml) tools, which will help to enable the early detection and prevention of chronic disease. this is, therefore, a very exciting development for aladdin.

h5欢乐红包扫雷源码aladdin will leverage its ai and ml capabilities for the purpose of assisting medical research by aiming to identify effective preventive medicinal practices, which in turn can optimise healthcare spending and generate savings for the healthcare industry.

wade menpes smith (chairman)

end of media release

OCTOBER 2018

22.10.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE ANNOUNCES IT NOW HAS A TOTAL OF 1.2 MILLION ANONYMISED EMRS ON ITS PLATFORMS GLOBALLY

h5欢乐红包扫雷源码(berlin, germany and london, england) 22nd october 2018 - aladdin blockchain technologies holding se (“aladdin”), a cutting-edge technology leader developing a new digital healthcare ecosystem that will revolutionise how members manage day-to-day healthcare, today announced it has increased the number of anonymised electronic medical records (emrs) of patients from china on its platform by 735,000. as of today, aladdin has also facilitated the data asset creation of a further 35,000 anonymised emrs onto its platform for indian patients. this brings the total number of anonymised emrs, on aladdin’s platforms to 1,210,000.

this represents significant progress into the indian and chinese markets, the numbers will continue to increase on a monthly basis feeding into the aladdin platforms. thereby improving the accuracy and effectiveness of aladdin’s ai and ml tools, which will help to enable the early detection and prevention of chronic disease. this is, therefore, a very exciting development for aladdin.

aladdin will leverage its artificial intelligence (ai) and machine learning (ml) capabilities for the purpose of assisting medical research by aiming to identify effective preventive medicinal practices, which in turn can optimise healthcare spending and generate savings for the healthcare industry.

h5欢乐红包扫雷源码wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

22.10.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES SE ANNOUNCES A MEMORANDUM OF UNDERSTANDING WITH THE NORWEGIAN CENTRE ON HEALTHY AGEING (NO-AGE)

(berlin, germany and london, england) 22nd october 2018 - aladdin blockchain technologies se (“aladdin”), a cutting-edge technology leader developing a new digital healthcare ecosystem that will revolutionise how members manage day-to-day healthcare, today announced they have entered into a non-legally binding memorandum of understanding with the norwegian centre on healthy ageing (no-age). as a result of this, an exciting partnership for research and development between aladdin and no-age is under discussion.

the norwegian centre on healthy ageing (no-age) is a norwegian integrated, interdisciplinary centre for human ageing research at international top level, with a translational goal to empower people to live longer, healthier, and more meaningful lives.

taking advantage of the strong inter-disciplinary anti-ageing research expertise and translational resources of no-age, in conjunction with the leading successful experience of aladdin in the fields of artificial intelligence (ai) and machine learning (ml), as well as in the production and marketing of clinical products, this collaboration will bring positive health outcomes to people who have ageing related chronic diseases, such as alzheimer’s disease, cardiovascular diseases and diabetes.

no-age intends to use aladdin’s strength in ai and ml to advance biomedical research and biomedical commercialisation. no-age and aladdin will work closely in predictive analytics, clinical trials and drug discovery. aladdin and no-age will use the extensive healthcare data available to no-age and develop an array of ml and ai toolkits to assist and accelerate research and study on age-related chronic diseases.

the current discussion about the first stage cooperation between aladdin and no-age is anchored in no-age primary teams located at the university of oslo (norway), with the involvement of leading antiageing researchers from the university of oxford (uk), the national institute on ageing (usa), stanford university (usa), and sun yatsen university (china). aladdin also plans to have further cooperation with other research parties in no-age.

h5欢乐红包扫雷源码this prospective partnership will enable no-age and aladdin to explore the opportunities for ai and ml to accelerate medical advances from biomedical research. aladdin expects to deliver an array of best-in-class machine learning and ai toolkits for clinical trial and drug discovery.

wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

SEPTEMBER 2018

12.09.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN ADDS BUPA DIRECTOR, DR AMIT PATEL TO ITS SENIOR ADVISORY TEAM

aladdin blockchain technologies ltd, london (“aladdin”) the 100% subsidiary of aladdin blockchain technologies holding se (“aladdin se”) today announces the appointment of dr amit patel as its lead uk healthcare advisor.

amit is director of new ventures at bupa where he is responsible for incubating and scaling new innovative businesses. he has previously held senior roles at bupa in strategy and m&a, new business development and digital proposition & product development. amit brings significant expertise in targeting and engaging with potential partners for collaboration. the appointment will add extensive uk market experience to the aladdin team, driving its strategy for data collection and acquisition in the uk.

h5欢乐红包扫雷源码prior to bupa, amit worked as a strategy consultant at lek – a top­-tier strategy consulting firm – advising fortune 500 companies and private equity investors on growth strategy and m&a. amit started his career in medicine and trained as a surgeon working in the nhs.

bupa is an international healthcare group providing clinics, hospitals, aged care centres and health insurance, headquartered in london, serving c.30 million customers worldwide, with revenues of £12.2 billion in 2017.

wade menpes smith (chairman)

end of media release

11.09.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN ADDS 55,000 ANONYMISED MEDICAL RECORDS TO ITS PLATFORM FOR INDIAN PATIENTS

h5欢乐红包扫雷源码aladdin has established a big data platform for the medical records of indian patients. aladdin ltd has also established a data processing team within india for the purpose of data asset creation and structuring data, so that it is of significant value for artificial intelligence (ai) and machine learning (ml) purposes.

h5欢乐红包扫雷源码as of today, aladdin ltd has facilitated the data asset creation of a further 55,000 anonymised electronic medical records (emr) onto its platform. this represents consistent progress into the indian market, the numbers will increase incrementally on a monthly basis feeding into the aladdin platform. this brings the total number of anonymised emrs, on aladdin’s platform for indian patients, to 80,000.

consistently increasing the quantity and quality of data on the aladdin platforms, drives the improvement in the accuracy and effectiveness of aladdin’s ai and ml tools. aladdin will utilise these tools to enable the early detection and prevention of chronic disease within india.

wade menpes smith (chairman)

end of media release

07.09.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN INTRODUCES DEEP LEARNING PROTOTYPE TO IDENTIFY DIABETES THROUGH RETINAL SCANS

h5欢乐红包扫雷源码introducing aladdin’s latest innovation building towards a revolutionary healthcare research and analytics as a service platform.

h5欢乐红包扫雷源码medical images represent a crucial part of diagnosing medical conditions. unassisted human delivered diagnoses based on such images is time­-consuming, highly complex and prone to high error rates.

delays in diagnosis and treatment can be life­-threatening and can have critical consequences for patients.

h5欢乐红包扫雷源码aladdin artificial intelligence healthcare applications support medical specialists to produce faster and more accurate diagnoses.

for example:

half a billion people worldwide suffer from diabetes. close to half of those with diabetes will experience retinopathy, which if undetected at an early stage, can result in blindness.

aladdin uses deep learning to process retinal images, identifying diabetes patients from healthy ones at an accuracy of 94.3% and can distinguish the different stages of diabetes with an accuracy of 84%.

h5欢乐红包扫雷源码earlier diagnosis leads to faster treatment and significantly improved survival rates.

h5欢乐红包扫雷源码aladdin ai preventative healthcare applications can be used to identify various conditions such as diabetes and cancer, driving vital innovation in healthcare.

h5欢乐红包扫雷源码follow this link to see videos of aladdin’s technology in action: http://nouub.icu/technologies/

wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

07.09.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN INCREASES THE NUMBER OF ANONYMISED ELECTRONIC MEDICAL RECORDS ON ITS PLATFORM IN CHINA

h5欢乐红包扫雷源码aladdin is building up a significant health data repository. on this aladdin will develop and apply the latest tools in artificial intelligence (ai) and machine learning (ml) in order to utilise the aladdin data repository to improve prevention, diagnosis and treatment of disease. the repository will consist of both electronic medical records (emr) and non­clinical data from a wide range of sources.

h5欢乐红包扫雷源码aladdin has already established a platform in china for the anonymised electronic medical records of chinese patients. they are in the process of creating a data processing team in china for the purpose of data asset creation and structuring data so that it is of significant value for ai and ml purposes.

aladdin has increased the number of anonymised electronic medical records of patients from north western china on its platform by 120,000. as of today, the total amount of emrs on aladdin’s platform in china is now c360,000.

aladdin will leverage its ai and ml capabilities for the purpose of assisting medical research by aiming to identify effective preventive medicinal practices, which in turn can optimise healthcare spending and generate savings for the healthcare industry.

h5欢乐红包扫雷源码aladdin will look to increase incrementally the number of electronic medical records on its platform in china. thereby improving the accuracy and effectiveness of aladdin’s ai and ml tools, which will help to enable the early detection and prevention of chronic disease within china.

h5欢乐红包扫雷源码wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

AUGUST 2018

31.08.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN CREATES A PROTOTYPE OPTICAL CHARACTER RECOGNITION (OCR) ENGINE FOR PROCESSING ELECTRONIC MEDICAL RECORDS

h5欢乐红包扫雷源码globally, the majority of medical records are only available as paper or scanned image documents, creating a significant challenge for medical research and worldwide healthcare improvements. aladdin has identified that the ability to harness this medical information and make it usable for machine learning (ml) and artificial intelligence (ai) purposes as crucial for the healthcare industry.

therefore, aladdin has developed a revolutionary optical character recognition (ocr) engine which converts medical record images to text. an essential step in developing ml and aiapplications.

using a dedicated, custom­built natural language toolkit and neural networks, aladdin’s medical ocr engine understands the context behind the information, handles different standards of clarity, brightness and contrast and can correct errors.

the medical record image is processed using the aladdin ocr engine. multiple languages are supported as part of the data capture.

generic ocr software can only convert the data from this record to simple text, which cannot be used for predictive machine learning algorithms without additional complex, human supervised processing.

aladdin’s medical ocr engine can recognize, capture and output both tabular and text medical data, ensuring a significantly higher conversion accuracy for medical records compared with other ocr products available on the market.

h5欢乐红包扫雷源码the machine learning algorithms can now fully utilize this output data without any further processing needed, providing instant, actionable insights for doctors and patients.

h5欢乐红包扫雷源码aladdin sees this as one of the facets of its new digital healthcare ecosystem. this in combination with the substantial quantity of data being uploaded to the ecosystem and the development of ml and ai tools will allow aladdin to bring significant innovation and efficiencies to the healthcare industry.

follow this link to see aladdin’s ocr engine in action: http://nouub.icu/technologies/

wade menpes smith (chairman)

end of media release

09.08.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN CREATES A PROTOTYPE FOR DIABETIC RETINOPATHY USING ARTIFICIAL INTELLIGENCE (AI) WITH 94% ACCURACY

diabetes is now a disease which affects c425 million people globally, according to the international diabetes federation. close to half of those with diabetes will experience retinopathy, a result of which can be blindness if not detected at an early stage.

h5欢乐红包扫雷源码aladdin has developed a prototype which uses an artificial intelligence­-based grading algorithm to detect, with high reliability and accuracy, referable diabetic retinopathy.

using 37,266 retinal images, of which 80% were used to train the deep neural networks algorithms and 20% were used to validate the performance, aladdin’s ai/ml team were able to teach the prototype to identify diabetes patients from healthy patients with the following high reliability:

h5欢乐红包扫雷源码accuracy to distinguish normal/diabetic retinopathy: 94.3% accuracy to distinguish no­n-proliferative/proliferative: 96.7%

h5欢乐红包扫雷源码furthermore, the prototype can distinguish the different stages of diabetes (none, mild, moderate, severe, proliferative) to 84.1% accuracy. these are exciting results at such an early stage of development. aladdin’s ai/ml team will now work to further the accuracy and reliability of the prototype using the increasing amounts of data on aladdin’s platform.

this development is particularly pertinent as the us food and drug administration (fda) approved, in april this year, the first software powered by artificial intelligence that replaces the need for a specialized doctor to interpret medical imagery. validating the assumption that there is significant demand for these technologies within the healthcare industry.

h5欢乐红包扫雷源码wade menpes smith (chairman)

end of media release

07.08.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN UPLOADS 240,000 ANONYMISED ELECTRONIC MEDICAL RECORDS TO ITS PLATFORM IN CHINA

h5欢乐红包扫雷源码aladdin is looking to build a significant health data repository. on this aladdin will harness and create the latest tools in artificial intelligence (ai) and machine learning (ml) to use the aladdin data repository to improve prevention, diagnosis and treatment of disease. the repository will consist of both electronic medical records (emr) and non­clinical data from a wide range of sources from transaction data and wearables to mobile apps.

aladdin had already established a platform in china for the anonymised electronic medical records of chinese patients. they are in the process of creating a data processing team in china for the purpose of data asset creation and structuring data, so that it is of significant value for ai and ml purposes.

as of today, aladdin has 240,000 electronic medical records of patients from north western china on its platform.

h5欢乐红包扫雷源码aladdin will leverage its ai and ml capabilities for the purpose of assisting medical research by aiming to identify effective preventive medicinal practices, which in turn can optimise healthcare spending and generate savings for the healthcare industry.

aladdin will look to increase incrementally the number of electronic medical records on its platform in china. thereby improving the accuracy and effectiveness of aladdin’s ai and ml tools, which will help to enable the early detection and prevention of chronic disease within china.

h5欢乐红包扫雷源码in order to improve the security around electronic medical records, aladdin intends to create and contribute its blockchain backed ecosystem to this data. in its current form, aladdin’s blockchain network delivers an immutable audit trail of access and change to electronic medical records held on a platform.

wade menpes smith (chairman)

end of media release

06.08.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN TO OPEN SOURCE ITS HYPERLEDGER FABRIC DEVELOPMENT KIT MAEJOR

aladdin’s initial blockchain project (genesis), is based on the blockchain technology known as hyperledger fabric (fabric). fabric is a highly modular architecture with a substantial number of subsystems. to make fabric suitable for a particular blockchain use case, such as medical record audit trail, it is necessary to assemble the subsystems using specific methods.

this is a cumbersome process and fabric, which is open source, does not provide tools to do this out­-of-­the-­box. to support aladdin’s first blockchain project, development effort and to make the development process efficient and scalable, aladdin has made an investment to extend the out­-of­-the-­box tools. the goal of the tool (maejor) is to enable developers to spin-­up blockchain configurations suitable for any use case with ease.

maejor has come to the attention of a workshop, sponsored by a hong kong government agency known as cyberport http://www.cyberport.hk/en, to train hyperledger fabric developers. as a result of this, aladdin has decided to make this tool open source and to send a lead member of the team to facilitate a workshop on the 27th and 28th august 2018.

aladdin looks to significantly enhance its reputation within the industry as a result of open sourcing its tools. as a company this puts aladdin on the cutting-­edge of technology and open sourcing the development kit will result in a vast peer review process that engenders trust within the blockchain community.

wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

03.08.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES HOLDING SE: ALADDIN LAUNCHES ITS PROOF OF CONCEPT (POC) BLOCKCHAIN NETWORK ‘GENESIS’

aladdin has launched its poc blockchain network based on hyperledger fabric. aladdin’s blockchain is a permissioned network that serves as a medical record audit trail, the first of its kind.

genesis ensures any interaction with medical records, is logged as a secure, immutable transaction, that cannot be tampered with. all network participants can be added by invitation only and benefit from a consistent, decentralised view of the full audit trail.

genesis consists of 3 nodes (for example 3 hospitals), where each transaction written to the blockchain, records: the action performed, the owner of the medical record, the user that interacts with the record and the date and time this action occurred.

this ensures that the sensitive data remains confidential but can be audited at any point in time. each transaction once recorded is distributed to each node, resulting in every node having an identical log of the audit trail.

genesis offers confidence to all network participants, guaranteeing that the full activity is undisputed and can be used as evidence in the event of repudiation.

h5欢乐红包扫雷源码the aladdin digital healthcare ecosystem helps build trust between network participants and gives patients peace of mind that their medical records are fully protected at all times.

follow this link to see genesis in action http://nouub.icu/technologies/

h5欢乐红包扫雷源码wade menpes smith (chairman)

h5欢乐红包扫雷源码end of media release

JULY 2018

31.07.2018
DGAP-Media

ALADDIN BLOCKCHAIN TECHNOLOGIES COMMENCES FIRST PHASE OF COMMERCIAL AGREEMENT WITH INDIAN PARTNER

h5欢乐红包扫雷源码aladdin blockchain technologies ltd, london, (“aladdin ltd.”) the 100% subsidiary of aladdin blockchain technologies holding se, (“aladdin”) has today commenced delivery of the first phase of its commercial agreement with ourhealthmate india (“ourhealthmate”).

our healthmate is india’s largest healthcare marketplace, which is partnered with 30,000 doctors in india. today, ourhealthmate offers more than 250,000 medical services at fixed cost through their platform offered by more than 2,000 healthcare centres in india, including the majority of the nation’s largest hospital chains. all these healthcare centres are partnered with ourhealthmate.

h5欢乐红包扫雷源码aladdin ltd has established a big data platform for the medical records of indian patients. aladdin ltd has also established a data processing team within india for the purpose of data asset creation and structuring data, so that it is of significant value for artificial intelligence (ai) and machine learning (ml) purposes.

as of today, aladdin ltd has facilitated the data asset creation of 25,000 anonymised electronic medical records onto its platform. this represents the first stage of development in india, the numbers will increase incrementally on a monthly basis feeding into the aladdin platform. thereby improving the accuracy and effectiveness of aladdin’s ai and ml tools, which will help to enable the early detection and prevention of chronic disease within india.

h5欢乐红包扫雷源码this forms the catalyst for creation of a blockchain backed ecosystem which will improve the immutability of audit trail of access and change to medical records on the aladdin platform.

wade menpes smith (chairman)

end of media release

红包扫雷h5游戏 红包扫雷平台是骗局吗 红包扫雷外挂苹果论坛 最火爆的红包扫雷 红包扫雷群hb90点cc